drugset
drugset / Trial / NCT03668314

Single and Multiple Ascending Dose and Food Effect PK Study in Healthy Adult and Elderly Subjects

NCT03668314 ↗

Phase 1 Completed 84 enrolled Alkermes, Inc. QPS Netherlands B.V. · collab
RandomizedParallel-groupTriple-blindOther

Summary

A three (3) part study to evaluate the safety, tolerability and PK of RDN-929

Timeline

Start
2018-10-10
Primary completion
2019-04-15
Completion
2019-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject RDN-929 Unknown 2 mg Oral

Indications

No indication recorded.